Advertisement
Advertisement
U.S. markets close in 2 hours
Advertisement
Advertisement
Advertisement
Advertisement

Alpha Teknova, Inc. (TKNO)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
8.58-0.97 (-10.16%)
As of 02:00PM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close9.55
Open9.80
Bid8.61 x 800
Ask8.91 x 900
Day's Range8.58 - 9.80
52 Week Range8.51 - 30.89
Volume19,366
Avg. Volume39,201
Market Cap240.605M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.66
Earnings DateMay 11, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est23.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for TKNO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Alpha Teknova, Inc.
    Daily – Vickers Top Buyers & Sellers for 08/27/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    9 months agoArgus Research
View more
  • GlobeNewswire

    Teknova Reports First Quarter 2022 Financial Results

    First quarter 2022 total revenue was $11.1 million, up 23% year-over-yearExcluding Sample Transport revenue, first quarter 2022 total revenue was $11.1 million, up 37% year-over-yearStrong cash position of $76.5 million supports investment in growth strategy HOLLISTER, Calif., May 11, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, development, and commercialization of drug therapies, novel vaccines, and molecula

  • GlobeNewswire

    Teknova to Report First Quarter 2022 Financial Results on May 11, 2022

    HOLLISTER, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the first quarter ended March 31, 2022, on Wednesday, May 11, 2022, following the close of market. Teknova will host a webcast and conference call on Wednesday, May 11, 2022

  • GlobeNewswire

    Teknova Reports Fourth Quarter and Full Year 2021 Financial Results

    Full year 2021 total revenue was $36.9 million, up 18% year-over-yearExcluding Sample Transport revenue of $1.5 million, full year 2021 total revenue was $35.4 million, up 31% year-over-yearCompany provides 2022 revenue guidance of $44-$48 millionHOLLISTER, Calif., March 15, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, development, and commercialization of drug therapies, novel vaccines, and molecular diagnost

Advertisement
Advertisement